treosulfan has been researched along with Benign Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Beléndez, C; Benítez, I; Bueno, D; Díaz de Heredia, C; Echecopar, C; Estival, P; Fernández Navarro, JM; Fuentes, C; Fuster, JL; Galán, V; González-Vicent, M; Margarit, A; Molina, B; Olivas, R; Palomo, P; Pascual, A; Pérez-Martínez, A; Plaza, M; Regueiro, A; Rifón, J; Ruz, B; Sissini, L; Urtasun, A | 1 |
| Bader, P; Beier, R; Ehlert, K; Eyrich, M; Greil, J; Gruhn, B; Holter, W; Hönig, M; Meisel, R; Müller, I; Nürnberger, W; Sauer, M; Schlegel, PG; Schulz, A; Stachel, KD; Suttorp, M; Sykora, KW; Urban, C; Wössmann, W; Zimmermann, M | 1 |
| LOEB, V | 1 |
| Cree, IA; Di Nicolantonio, F; Glaysher, S; Johnson, P; Knight, LA; Mercer, S; Sharma, S; Whitehouse, P | 1 |
| Mauch, C | 1 |
| Clare, MG; Jones, WG; Taylor, JH | 1 |
| Baumgart, J; Eberhardt, W; Harstrick, A; Hilger, RA; Oberhoff, C; Scheulen, ME; Seeber, S; Skorzec, M | 1 |
| Baumgart, J; Berdel, WE; Bojko, P; Bornhäuser, M; Casper, J; Ehninger, G; Freund, M; Harstrick, A; Hilger, RA; Josten, KM; Oberhoff, C; Scheulen, ME; Schindler, AE; Seeber, S; Wolf, HH | 1 |
3 trial(s) available for treosulfan and Benign Neoplasms
| Article | Year |
|---|---|
Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Austria; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Common Variable Immunodeficiency; Disease-Free Survival; Female; Follow-Up Studies; Germany; Humans; Infant; Male; Metabolism, Inborn Errors; Myeloablative Agonists; Neoplasms; Registries; Risk Factors; Survival Rate; Transplantation Conditioning | 2013 |
Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Busulfan; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Treatment Outcome | 1998 |
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies.
Topics: Adult; Antineoplastic Agents, Alkylating; Busulfan; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms; Transplantation, Autologous | 2000 |
5 other study(ies) available for treosulfan and Benign Neoplasms
| Article | Year |
|---|---|
Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).
Topics: Adolescent; Child; Child, Preschool; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Neoplasms; Retrospective Studies; Transplantation Conditioning | 2023 |
DIHYDROXYBUSULFAN (NSC-39069) IN CHRONIC MYELOCYTIC LEUKEMIA AND MISCELLANEOUS MALIGNANT NEOPLASMS.
Topics: Busulfan; Drug Therapy; Geriatrics; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Neoplasms; Toxicology | 1964 |
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours.
Topics: Adenocarcinoma; Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busulfan; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Colorectal Neoplasms; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Gefitinib; Gemcitabine; Humans; Melanoma; Neoplasms; Neoplasms, Unknown Primary; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Quinazolines; Sarcoma; Skin Neoplasms; Stomach Neoplasms; Uveal Neoplasms | 2004 |
[Metronomic chemotherapy. Should we change our thinking in the treatment of advanced tumors?].
Topics: Administration, Oral; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bevacizumab; Breast Neoplasms; Busulfan; Cyclooxygenase 2 Inhibitors; Cyclophosphamide; Drug Therapy, Combination; Female; Forecasting; Humans; Male; Melanoma; Neoplasm Metastasis; Neoplasms; Prospective Studies; Quality of Life; Skin Neoplasms; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
Sister chromatid exchanges in human lymphocytes exposed to single cytotoxic drugs in vivo or in vitro.
Topics: Adult; Aged; Antineoplastic Agents; Busulfan; Cells, Cultured; Chlorambucil; Crossing Over, Genetic; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Lymphocytes; Male; Middle Aged; Neoplasms; Sister Chromatid Exchange | 1982 |